A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
Kimura H, Kanahara N, Komatsu N, Ishige M, Muneoka K, Yoshimura M, Yamanaka H, Suzuki T, Komatsu H, Sasaki T, Hashimoto T, Hasegawa T, Shiina A, Ishikawa M, Sekine Y, Shiraishi T, Watanabe H, Shimizu E, Hashimoto K, Iyo M.
Kimura H, et al. Among authors: hasegawa t.
Schizophr Res. 2014 May;155(1-3):52-8. doi: 10.1016/j.schres.2014.02.022. Epub 2014 Mar 23.
Schizophr Res. 2014.
PMID: 24667073
Free article.